ArticleScientific reports2021

A novel mineralocorticoid receptor antagonist, 7,3',4'-trihydroxyisoflavone improves skin barrier function impaired by endogenous or exogenous glucocorticoids.

Hanil Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.